中国当代医药2024,Vol.31Issue(28) :102-105.

麝香保心丸联合阿司匹林、氯吡格雷在急性冠脉综合征经皮冠状动脉介入术术后寒凝心脉证患者中的应用效果

Application effect of Shexiang Baoxin Pills combined with Aspirin Enter-ic-coated Tablet and Clopidogrel Bisulfate Tablet on patients with cold coagulation and pulse syndrome after percutaneous coronary intervention in acute coronary syndrome

刘筝 熊润德
中国当代医药2024,Vol.31Issue(28) :102-105.

麝香保心丸联合阿司匹林、氯吡格雷在急性冠脉综合征经皮冠状动脉介入术术后寒凝心脉证患者中的应用效果

Application effect of Shexiang Baoxin Pills combined with Aspirin Enter-ic-coated Tablet and Clopidogrel Bisulfate Tablet on patients with cold coagulation and pulse syndrome after percutaneous coronary intervention in acute coronary syndrome

刘筝 1熊润德1
扫码查看

作者信息

  • 1. 湖南省岳阳市人民医院药学部,湖南岳阳 414000
  • 折叠

摘要

目的 探讨麝香保心丸联合阿司匹林肠溶片、硫酸氢氯吡格雷片联合对急性冠脉综合征经皮冠状动脉介入术(PCI)术后寒凝心脉证患者的疗效.方法 选取2022年6月至2023年5月岳阳市人民医院收治的120例急性冠脉综合征PCI术后寒凝心脉证患者作为研究对象,采用随机数字表法分为对照组与研究组,各组均60例.对照组在PCI术后实施阿司匹林肠溶片联合硫酸氢氯吡格雷片治疗,在此基础上研究组辅以麝香保心丸治疗.比较两组临床疗效及安全性,治疗前后中医证候、心功能指标[左室射血分数(LVEF)及脑尿钠肽(BNP)]及炎症因子[肿瘤坏死因子-α(TNF-α)、高敏C反应蛋白(hs-CRP)及白细胞介素-18(IL-18)]水平.结果 研究组患者总有效率高于对照组,差异有统计学意义(P<0.05).两组患者治疗后中医证候积分、BNP、TNF-α、hs-CRP及IL-18低于治疗前,两组患者治疗后LVEF水平高于治疗前,差异有统计学意义(P<0.05),研究组患者治疗后中医证候积分、BNP、TNF-α、hs-CRP及IL-18低于对照组,研究组患者治疗后LVEF水平高于对照组,差异有统计学意义(P<0.05).两组均未发生不良反应.结论 麝香保心丸联合阿司匹林肠溶片、硫酸氢氯吡格雷片能改善急性冠脉综合征PCI术后寒凝心脉证患者心功能,减轻其炎症反应,并提升治疗效果.

Abstract

Objective To explore the curative effect of Shexiang Baoxin Pills combined with Aspirin Enteric-coated Tablet and Clopidogrel Bisulfate Tablet on patients with cold coagulation and pulse syndrome after percutaneous coronary interven-tion(PCI)for acute coronary syndrome.Methods A total of 120 patients with cold coagulation cardio-pulse syndrome after PCI treated in Yueyang People's Hospital from June 2022 to May 2023 were selected as the study objects,and they were di-vided into the control group and the study group according to random number table method(each group had 60 cases).The con-trol group was treated with Aspirin Enteric-coated Tablet combined with Clopidogrel Bisulfate Tablet after PCI,and the study group was treated with Shexiang Baoxin Pills.The clinical efficacy and safety of the two groups were compared,as well as the traditional Chinese medicine syndromes,cardiac function indexes(left ventricular ejection fraction[LVEF]and brain na-triuretic peptide[BNP])and the levels of inflammatory factors(tumor necrosis factor-α[TNF-α],high-sensitive C-reactive protein[hs-CRP]and interleukin-18[IL-18])before and after treatment.Results The total effective rate of the study group was higher than that of the control group,and the difference was statistically significant(P<0.05).Traditional Chinere medicine syndrome score,BNP,TNF-α,hs-CRP and IL-18 after treatment were lower than those before treatment,and LVEF level after treatment was higher than that before treatment,the differences were statistically significant(P<0.05).The traditional Chinese medicine syndrome scores,BNP,TNF-α,hs-CRP and IL-18 of the study group were lower than those of the control group after treatment,and the LVEF level of the study group was higher than that of the control group after treatment,with statistical significances(P<0.05).No adverse reactions occurred in both groups.Conclusion Shexiang Baoxin Pills com-bined with Aspirin Enteric-coated Tablet and Clopidogrel Bisulfate Tablet can improve the cardiac function of patients with cold coagulation and pulse syndrome after PCI of acute coronary syndrome,reduce their inflammatory reaction and improve the therapeutic effect.

关键词

麝香保心丸/抗血小板/寒凝心脉/急性冠脉综合征

Key words

Shexiang Baoxin Pills/Antiplatelet/Cold coagulation and pulse syndrome/Acute coronary syndrome

引用本文复制引用

出版年

2024
中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
段落导航相关论文